Stockhead’s resident Health and Biotech expert Tim Boreham is putting down the microscope and picking up the microphone for another installment of The Health Kick Podcast.
In this episode Tim interviews Michael Harsh, non-executive director at Imagion Biosystems (ASX:IBX).
Imagion Biosystems is developing a diagnostic imaging tool called Magsense, which is based on injecting nanoparticles with magnetic fields to detect tumors such as breast cancers.
Listen to the podcast.
Executive Chairman Bob Proulx on Pitt Street Research’s Stocks Down Under Podcast: Getting ready for a Phase 2 Study
August 21, 2025
Earlier this month, our own Bob Proulx, Executive Chairman of Imagion Biosystems, had the opportunity to join Stuart Roberts on Pitt Street Research’s podcast Stocks